These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 25933543)
21. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles. Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872 [TBL] [Abstract][Full Text] [Related]
22. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy. Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942 [TBL] [Abstract][Full Text] [Related]
23. Redox-responsive degradable prodrug nanogels for intracellular drug delivery by crosslinking of amine-functionalized poly(N-vinylpyrrolidone) copolymers. Peng H; Huang X; Melle A; Karperien M; Pich A J Colloid Interface Sci; 2019 Mar; 540():612-622. PubMed ID: 30690386 [TBL] [Abstract][Full Text] [Related]
24. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery. Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909 [TBL] [Abstract][Full Text] [Related]
25. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers. Dong DW; Tong SW; Qi XR J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848 [TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release. Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725 [TBL] [Abstract][Full Text] [Related]
27. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug. Ling L; Ismail M; Du Y; Yao C; Li X Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133 [TBL] [Abstract][Full Text] [Related]
28. Cell-targeted, dual reduction- and pH-responsive saccharide/lipoic acid-modified poly(L-lysine) and poly(acrylic acid) polyionic complex nanogels for drug delivery. How SC; Chen YF; Hsieh PL; Wang SS; Jan JS Colloids Surf B Biointerfaces; 2017 May; 153():244-252. PubMed ID: 28267669 [TBL] [Abstract][Full Text] [Related]
29. pH-responsive targeted and controlled doxorubicin delivery using hyaluronic acid nanocarriers. Gurav DD; Kulkarni AS; Khan A; Shinde VS Colloids Surf B Biointerfaces; 2016 Jul; 143():352-358. PubMed ID: 27022876 [TBL] [Abstract][Full Text] [Related]
30. Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects. Yao M; Ma X; Zhang X; Shi L; Liu T; Liang X; Zhao H; Li X; Li L; Gao H; Jia B; Wang F Theranostics; 2019; 9(3):747-760. PubMed ID: 30809306 [TBL] [Abstract][Full Text] [Related]
31. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery. Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of cross-linked carboxyl poly(glycerol methacrylate) and its application for the controlled release of doxorubicin. Gu W; Ma Y; Zhu C; Chen B; Ma J; Gao H Eur J Pharm Sci; 2012 Oct; 47(3):556-63. PubMed ID: 22884627 [TBL] [Abstract][Full Text] [Related]
33. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery. Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122 [TBL] [Abstract][Full Text] [Related]
34. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin. Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and Characterization of Dual-Sensitive Fluorescent Nanogels for Enhancing Drug Delivery and Tracking Intracellular Drug Delivery. Wu SY; Debele TA; Kao YC; Tsai HC Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534813 [TBL] [Abstract][Full Text] [Related]
36. Hydrophilicity/Hydrophobicity reversable and redox-sensitive nanogels for anticancer drug delivery. Yang H; Wang Q; Chen W; Zhao Y; Yong T; Gan L; Xu H; Yang X Mol Pharm; 2015 May; 12(5):1636-47. PubMed ID: 25833093 [TBL] [Abstract][Full Text] [Related]
37. Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects. Hu J; Xie L; Zhao W; Sun M; Liu X; Gao W Chem Commun (Camb); 2015 Jul; 51(57):11405-8. PubMed ID: 26086450 [TBL] [Abstract][Full Text] [Related]
38. An imaging-guided platform for synergistic photodynamic/photothermal/chemo-therapy with pH/temperature-responsive drug release. Lv R; Yang P; He F; Gai S; Yang G; Dai Y; Hou Z; Lin J Biomaterials; 2015 Sep; 63():115-27. PubMed ID: 26093792 [TBL] [Abstract][Full Text] [Related]
39. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride. Zhang B; Yang X; Wang Y; Zhai G Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455 [TBL] [Abstract][Full Text] [Related]
40. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]